JP2006507797A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006507797A5 JP2006507797A5 JP2004506346A JP2004506346A JP2006507797A5 JP 2006507797 A5 JP2006507797 A5 JP 2006507797A5 JP 2004506346 A JP2004506346 A JP 2004506346A JP 2004506346 A JP2004506346 A JP 2004506346A JP 2006507797 A5 JP2006507797 A5 JP 2006507797A5
- Authority
- JP
- Japan
- Prior art keywords
- hpv
- polynucleotide
- peptide
- polypeptide
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA200203957 | 2002-05-17 | ||
| PCT/IB2003/001912 WO2003097673A2 (en) | 2002-05-17 | 2003-05-19 | Chimeric human papillomavirus 16 l1 proteins comprising an l2 peptide,virus-like particles prepared therefrom and a method for preparing the particles. |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010137490A Division JP2010263899A (ja) | 2002-05-17 | 2010-06-16 | Ｌ２ペプチドを含むキメラ・ヒト・パピローマウイルス１６ｌ１タンパク質、それから調製したウイルス様粒子および該粒子の調製方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006507797A JP2006507797A (ja) | 2006-03-09 |
| JP2006507797A5 true JP2006507797A5 (OSRAM) | 2006-06-29 |
| JP4614765B2 JP4614765B2 (ja) | 2011-01-19 |
Family
ID=29550639
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004506346A Expired - Fee Related JP4614765B2 (ja) | 2002-05-17 | 2003-05-19 | Ｌ２ペプチドを含むキメラ・ヒト・パピローマウイルス１６ｌ１タンパク質、それから調製したウイルス様粒子および該粒子の調製方法 |
| JP2010137490A Withdrawn JP2010263899A (ja) | 2002-05-17 | 2010-06-16 | Ｌ２ペプチドを含むキメラ・ヒト・パピローマウイルス１６ｌ１タンパク質、それから調製したウイルス様粒子および該粒子の調製方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010137490A Withdrawn JP2010263899A (ja) | 2002-05-17 | 2010-06-16 | Ｌ２ペプチドを含むキメラ・ヒト・パピローマウイルス１６ｌ１タンパク質、それから調製したウイルス様粒子および該粒子の調製方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7407807B2 (OSRAM) |
| EP (1) | EP1506222B2 (OSRAM) |
| JP (2) | JP4614765B2 (OSRAM) |
| AT (1) | ATE424409T1 (OSRAM) |
| AU (1) | AU2003232951B2 (OSRAM) |
| CA (1) | CA2486450C (OSRAM) |
| CY (1) | CY1109257T1 (OSRAM) |
| DE (1) | DE60326449D1 (OSRAM) |
| DK (1) | DK1506222T3 (OSRAM) |
| ES (1) | ES2323634T5 (OSRAM) |
| PT (1) | PT1506222E (OSRAM) |
| SI (1) | SI1506222T1 (OSRAM) |
| WO (1) | WO2003097673A2 (OSRAM) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0228715D0 (en) * | 2002-12-09 | 2003-01-15 | Glaxosmithkline Biolog Sa | Vaccine |
| EP1883701B1 (en) | 2005-04-29 | 2012-01-18 | University of Cape Town | Expression of viral proteins in plants |
| ES2310062B1 (es) | 2005-07-15 | 2009-11-13 | Bionostra, S.L. | Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones. |
| CN1328287C (zh) * | 2005-12-29 | 2007-07-25 | 西安交通大学 | Hpv16 l1蛋白模拟肽及其用于制备hpv16诊断试剂和疫苗的用途 |
| WO2009055491A2 (en) * | 2007-10-22 | 2009-04-30 | University Of Rochester | Respiratory syncytial virus vaccine based on chimeric papillomavirus virus-like particles or capsomeres |
| AU2010264695A1 (en) * | 2009-06-25 | 2012-01-19 | Glaxosmithkline Biologicals S.A. | Novel human papillomavirus (HPV) protein constructs and their use in the prevention of HPV disease |
| WO2011017162A2 (en) * | 2009-08-03 | 2011-02-10 | The Johns Hopkins University | Methods for enhancing antigen-specific immune responses |
| JP6153866B2 (ja) | 2010-05-25 | 2017-06-28 | キアゲン ガイサーズバーグ アイエヌシー． | 迅速なハイブリッド捕捉アッセイ、及び関連する戦略的に切断されたプローブ |
| JP6228922B2 (ja) * | 2011-12-01 | 2017-11-08 | ユニバーシティ・オブ・ケープ・タウンＵｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｐｅ Ｔｏｗｎ | Ｈｐｖキメラ粒子 |
| WO2015009853A1 (en) * | 2013-07-16 | 2015-01-22 | University Of Louisville Research Foundation, Inc. | Compositions for mucusal delivery, useful for treating papillomavirus infections |
| JP7017811B2 (ja) * | 2020-02-13 | 2022-02-09 | 国立研究開発法人農業・食品産業技術総合研究機構 | ウイルス様粒子及びその使用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5618536A (en) * | 1992-09-03 | 1997-04-08 | The United States Of America As Represented By The Department Of Health And Human Services | Chimeric papillomavirus-like particles |
| PT809700E (pt) * | 1994-10-07 | 2006-09-29 | Univ Loyola Chicago | Particulas semelhantes ao papilomavirus e proteinas de fusao, assim como metodos para a sua producao |
| GB9621091D0 (en) * | 1996-10-09 | 1996-11-27 | Fondation Pour Le Perfectionem | Attenuated microorganisms strains and their uses |
| US6228368B1 (en) † | 1997-10-06 | 2001-05-08 | Loyola University Of Chicago | Papilloma virus capsomere formulations and method of use |
| US6926897B1 (en) † | 1998-03-24 | 2005-08-09 | Medigene Aktiengesellschaft | Medicament for the avoidance or treatment of papillomavirus-specific tumour |
| DE19812941A1 (de) † | 1998-03-24 | 1999-10-07 | Medigene Ag | Arzneimittel zur Vermeidung oder Behandlung von Papillomavirusspezifischem Tumor |
| CA2339324C (en) * | 1998-08-14 | 2011-05-31 | Robert S. Lowe | Protein delivery system using human papillomavirus virus-like particles |
| GB9921146D0 (en) † | 1999-09-07 | 1999-11-10 | Smithkline Beecham Biolog | Novel composition |
| CN107080833A (zh) † | 2009-04-10 | 2017-08-22 | 约翰·霍普金斯大学 | 作为广谱人类乳头状瘤病毒（hpv）疫苗的乳头状瘤病毒样颗粒（vlp） |
-
2003
- 2003-05-19 DE DE60326449T patent/DE60326449D1/de not_active Expired - Lifetime
- 2003-05-19 PT PT03727750T patent/PT1506222E/pt unknown
- 2003-05-19 AU AU2003232951A patent/AU2003232951B2/en not_active Ceased
- 2003-05-19 ES ES03727750T patent/ES2323634T5/es not_active Expired - Lifetime
- 2003-05-19 JP JP2004506346A patent/JP4614765B2/ja not_active Expired - Fee Related
- 2003-05-19 WO PCT/IB2003/001912 patent/WO2003097673A2/en not_active Ceased
- 2003-05-19 DK DK03727750T patent/DK1506222T3/da active
- 2003-05-19 SI SI200331600T patent/SI1506222T1/sl unknown
- 2003-05-19 AT AT03727750T patent/ATE424409T1/de active
- 2003-05-19 US US10/514,878 patent/US7407807B2/en not_active Expired - Fee Related
- 2003-05-19 CA CA2486450A patent/CA2486450C/en not_active Expired - Fee Related
- 2003-05-19 EP EP03727750A patent/EP1506222B2/en not_active Expired - Lifetime
-
2008
- 2008-07-16 US US12/174,104 patent/US8163557B2/en not_active Expired - Lifetime
-
2009
- 2009-06-04 CY CY20091100595T patent/CY1109257T1/el unknown
-
2010
- 2010-06-16 JP JP2010137490A patent/JP2010263899A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6599508B1 (en) | Papilloma virus-like particles, fusion proteins as well as processes for their production | |
| Shi et al. | Papillomavirus pseudovirus: a novel vaccine to induce mucosal and systemic cytotoxic T-lymphocyte responses | |
| JP2018518172A5 (OSRAM) | ||
| JP2006501825A5 (OSRAM) | ||
| CA2342289A1 (en) | Treatment of cervical cancer | |
| DK2910566T3 (en) | Truncated L1 protein of human papillomavirus 11 | |
| US11179456B2 (en) | HPV vaccine | |
| JP2007507207A5 (OSRAM) | ||
| JP6958818B2 (ja) | ヒトパピローマウイルスタイプ５８のｌ１タンパク質の突然変異 | |
| JP2003511010A (ja) | ヒト細胞中での発現用に最適化された合成ヒトパピローマウイルス遺伝子 | |
| EP2154149B1 (en) | A truncated l1 protein of human papillomavirus 6 | |
| JP2006507797A5 (OSRAM) | ||
| WO2012159562A1 (zh) | 截短的人乳头瘤病毒33型l1蛋白 | |
| US9364529B2 (en) | Truncated L1 protein of human papillomavirus type 18 | |
| JP2019502404A5 (OSRAM) | ||
| Gissmann et al. | Therapeutic vaccines for human papillomaviruses | |
| JP5545209B2 (ja) | 免疫原性を有する物質 | |
| KR102803235B1 (ko) | 타입 39 인유두종 바이러스 l1 단백질의 돌연변이체 | |
| CN101036784B (zh) | 一种乙型肝炎治疗性细胞毒性t细胞表位疫苗及其制备方法 | |
| US6991795B1 (en) | Protein delivery system using human papillomavirus virus-like particles | |
| WO2003097673B1 (en) | Chimeric human papillomavirus 16 l1 proteins comprising an l2 peptide,virus-like particles prepared therefrom and a method for preparing the particles. | |
| BR112013000996B1 (pt) | Proteína l1 hpv58 truncada, ácido nucléico isolado, vetor, célula hospedeira, partícula do tipo viral hpv58, composição, composição farmacêutica ou vacina, método para obter uma proteína l1 hpv58 truncada, método para preparar a partícula do tipo viral hpv58, método para preparar uma vacina, e uso da proteína l1 hpv58 truncada | |
| HUP0202770A2 (hu) | Humán papillómavírus oltóanyag | |
| JP2012501351A5 (OSRAM) | ||
| CN105801704B (zh) | 一种具有抗宫颈癌细胞活性的重组疫苗构建方法及应用 |